Chinese Soft Exosuit Developer Xirun Medical Secures Tens of Millions in Pre-A Funding to Accelerate Full-Cycle, Multi-Scenario Rehabilitation Solutions

VCBeat has learned that the soft rehabilitation robotics companyNingbo Xirun Medical Technology Co., Ltd. (hereinafter referred to as“Xirun Medical”)Announces Completion of Tens of Millions in FundingPre-Series A financing round. This round of financing was led byNingbo Fuchuang Venture Capital FundandNingbo Angel FundCo-investment.

Actual Photos of Xirun Medical’s Environment

Since its establishment in 2019, Xirun Medical has been deeply engaged in the field of rehabilitation technology. Leveraging the Rehabilitation Robot Translation Platform at Shanghai Jiao Tong University, the company is dedicated to the research and development of rehabilitation robot technologies, creating a series of soft rehabilitation robots. These products aim to facilitate better patient recovery, improve quality of life, and help patients regain vitality. The company’s products hold more than 40 patents and have obtained medical device registrations from China’s National Medical Products Administration (NMPA), the European Union’s CE marking, and the U.S. Food and Drug Administration (FDA).

Xirun Medical Shines at Major Competitions

To address the rehabilitation needs of patients with limb impairments caused by neurological injuries such as stroke, hand trauma, spinal cord injury, and burns, Xirun Medical has independently developed an innovative rehabilitation product—the Soft Robotic Hand Rehabilitation System. This system integrates cutting-edge technologies, including passive rehabilitation, master-slave mirror therapy, and motor imagery rehabilitation based on brain-computer interface (BCI) technology. It helps alleviate finger joint edema and stiffness, enhances hand muscle strength, promotes neural recovery in the brain, and assists patients in making the most of the critical “golden period” for rehabilitation.

Xirun Medical's Self-Developed Soft Robotic Hand Rehabilitation System

Xirun Medical’s core competitiveness lies in its mastery of soft robotics technology and leading neurorehabilitation algorithms. Through deep integration of hardware and software, the company has developed biomimetic soft robotic structures that not only enhance flexibility and versatility but also significantly reduce the risk of secondary injury associated with traditional rigid robots, thereby ensuring safe and effective rehabilitation.

Meanwhile, the multi-sensor fusion control algorithm ensures the precision and visualization of rehabilitation training, establishing a comprehensive rehabilitation pathway from limb stimulation to progress monitoring. This accelerates the recovery process and enhances therapeutic outcomes. The system features a modular design for easy assembly, offering a short production cycle, a compact form factor, and user-friendly operation.

In terms of product portfolio, Xirun Medical has launched three major series: the Flagship Medical Edition, the Professional Rehabilitation Edition, and the Portable Rehabilitation Edition. Comprising more than ten models with a wide price range from several thousand to hundreds of thousands of yuan, these products cater to comprehensive rehabilitation needs across hospitals, communities, and households, helping patients seize the “golden period” of rehabilitation.

In terms of commercialization, Xirun Medical has established a strategic framework characterized by “parallel expansion in domestic and international markets” and “synergy between B-end and C-end operations.” The company has formed a closed-loop service model encompassing “diagnosis and treatment – rehabilitation – assessment,” delivering integrated solutions that combine products, services, and digitalization. Currently, the company has partnered with multiple distributors both in China and abroad, and collaborated with dozens of hospitals to jointly develop “benchmark hospitals,” achieving steady revenue growth.

Recently, Zhejiang Television’s News Channel featured a special report on Xirun Medical. In an exclusive interview, General Manager Meng Mingqiang stated, “Our soft robotics have achieved industry-leading performance in terms of flexibility and force output. This enables us to deliver effective rehabilitation outcomes for patients at an affordable price, providing access to our comprehensive, all-scenario rehabilitation services. Currently, our hand function rehabilitation products are being used clinically in multiple hospitals in Shanghai and have received consistent acclaim from both physicians and patients. Clinical trials conducted in hospital settings demonstrated that patients’ hand function scores improved by an average of 30% over five weeks, indicating highly significant efficacy.”

Meng Mingqiang, General Manager of Xirun Medical, Interviewed by Zhejiang Television News Channel

Regarding this financing,Meng Mingqiang, General Manager of Xirun MedicalHe stated, “We are grateful for the investors’ trust and support, which have injected new vitality and hope into Xirun Medical. This financing round not only provides us with valuable financial backing but also represents a significant step forward in driving innovative development within the rehabilitation medicine sector. In 2016, we embarked on our entrepreneurial journey alongside professors from Shanghai Jiao Tong University, aiming to translate our rehabilitation robotics technology into commercial products. At that time, exoskeleton robot technology faced major challenges, namely its high complexity and prohibitive cost, which limited its application scope. Consequently, in 2019, we pivoted to the emerging field of soft rehabilitation robotics, leveraging soft robotic technologies to develop our comprehensive product portfolio. This approach enables patients to receive effective rehabilitation care across the continuum—from the hospital ICU, to the ward bed, and finally at home—thereby delivering a more efficient, comfortable, and affordable rehabilitation experience.”

“We are fully aware that in this highly competitive rehabilitation robotics market, maintaining a leading position requires continuous innovation and relentless progress. With this financing round, we will further increase our investments in R&D, product optimization, and market expansion, continually launching more innovative products and services to meet the growing demand for rehabilitation medical care. Meanwhile, we will actively seek collaborations with domestic and international medical institutions, research organizations, and industry partners to jointly promote advancements and development in the field of rehabilitation medicine. In the future, we will continue to uphold our core values of ‘Innovation, Quality, and Service,’ constantly enhancing product quality and service standards to provide better solutions for patients and healthcare institutions.”

Shang Jing, Managing Partner at Fuchuangtoustated: “With the aging of China’s population structure and the rise in economic levels, we are optimistic about the development prospects of the rehabilitation industry. The Xirun team has many years of practical exploration in rehabilitation equipment, deeply understands clinical needs, integrates medicine with engineering, and has developed a series of more cost-effective products. Fudan University Ningbo Institute’s broader ecosystem has introduced them to the Qianwan New Area, a hotbed for scientific and technological innovation, providing early-stage investment and incubation space support. We hope to provide Xirun with ample financial resources and a favorable entrepreneurial atmosphere, enabling them to focus wholeheartedly on overcoming more ‘chokehold’’Technology empowers rehabilitation medicine with the wings of artificial intelligence, benefiting millions of households.

Ningbo Fuchuang Venture Capital Fund is an early-stage investment fund jointly established by the broader ecosystem of Fudan University’s Ningbo Research Institute and the Ningbo Qianwan New Area, with a focus on facilitating the commercialization of scientific and technological achievements. The fund concentrates on industries such as life and health, semiconductors, new energy, and new materials, adhering to the principle of “investing in specialized, small, early-stage, and hard-tech ventures.” It provides angel and venture capital funding to high-quality startup projects intending to settle in the Qianwan New Area, continuously promoting the industrialization of major scientific and technological achievements and fostering innovation and entrepreneurship among high-level talents, thereby injecting strong momentum into the cultivation and development of new quality productive forces in Ningbo.